Other

Stopping transplant drugs before conception benefits fetus

Research suggests that fetal exposure to mycophenolic acid products (MPA)—which are drugs taken by transplant recipients to prevent rejection—may increase the risk of birth defects and spontaneous abortions. Results of ...

page 4 from 6